Company news
Skylight Health Group Inc. news in 2019
Skylight Health Group Inc.'s news releases, calls and decks from 2019, newest first.
CB2 Insights Announces Industry’s First Full-Scale Hemp-based Cannabidiol (CBD) Prospective Trial in Partnership with GL Brands (Formerly Freedom Leaf Inc.)
December 16, 2019
CB2 Insights Completes Full-Scale Platform to Connect Disparate Data Systems
December 12, 2019
CB2 Insights Launches Warrant Incentive Program
December 11, 2019
CB2 Insights Announces Collaboration with FCM Global to Support Medical Cannabis R&D in Colombia
December 3, 2019
CB2 Insights to Participate at Piper Jaffray’s 31st Annual Healthcare Conference
November 14, 2019
CB2 Insights Announces Record Revenue of $4.2 million for the Third Quarter 2019; Sequential Growth of 29%
November 8, 2019
CB2 Insights Announces Record Preliminary Unaudited Q3 2019 Revenue of $4.2 Million and Details for Earnings Call
November 1, 2019
VIVO and CB2 Insights Enter Technology and Research Partnership
October 29, 2019
CB2 Insights Licenses Electronic Data Capture Software to MyAccess Clinics for Use In the UK
September 19, 2019
CB2 Insights Announces Appointment of Medical Director in Colombia and Enters Market with Cannabis Research Focus
September 3, 2019
CB2 Insights Reports Second Quarter Fiscal 2019 Financial Results, Sees Positive Impact from New Acquisitions
August 28, 2019
CB2 Insights to Host Q2 2019 Earnings Call on August 28, 2019
August 20, 2019
CB2 Insights Announces New Appointment to Board of Directors with Medical Cannabis and Capital Markets Executive
August 1, 2019
CB2 Insights Adds Former Johnson & Johnson Executive as Director
July 31, 2019
CB2 Insights Selected by Drug Science as Research Technology Platform for the UK’s Largest Medical Cannabis Pilot
July 18, 2019
CB2 Insights and Premier Health Group Move to Second Phase of Primary Care Physician Tools for Medical Cannabis Evaluations
July 9, 2019
CB2 Insights Expands Clinical Division into New Jersey with the Asset Acquisition of New Jersey Alternative Medicine Clinics
June 25, 2019
CB2 Insights Announces Annual General & Special Meeting of Shareholders and Corporate Update
June 24, 2019
CB2 Insights Posts Strong Growth in Clinical Revenue and Drives Operating Efficiencies in Q1 2019
May 30, 2019
CB2 Insights to Present at the 9th Annual LD Micro Invitational in Bel-Air
May 28, 2019
CB2 Insights to Host Q12019 Earnings Call on May 31, 2019
May 27, 2019
CB2 Insights Announces Ticker Symbol Change on OTCQB
May 17, 2019
CB2 Insights Expands Board with Teladoc Executive Marc Adelson, Appoints David Danziger as Chairman and Adopts Advance Notice Bylaw
May 2, 2019
CB2 Insights Announces FY2018 Financial Results After Transformative Year
April 30, 2019